The EEC’s Department for Sanitary, Phytosanitary and Veterinary Measures is preparing to hold an open event to answer the questions from the market players regarding the deeper integration of the common Eurasian market of veterinary medicinal products.
Imports of veterinary medicinal products have been slowly recovering following the changes in market access conditions. The process has been slowed down by long GMP audits procedure, the difficult resumption of production after being GMP certified and the delivery of necessary reagents.
March 13 marked the start of a transition towards the Eurasian Economic Union’s universal norms and rules regarding veterinary medicinal products.
Russia has not imported vaccines for cats and dogs since September 1, 2024
The EEC Council’s Decision No.101 of September 27, 2023 provides for mutual recognition of EAEU GMP certificates, granting the competent national authorities the right to certify a local manufacturer not later than March 13, 2024. As of now, five companies from Belarus can exercise this right.
AVPHARM compiled the results of two months since market release procedure came into force
Further work with the Russian representative office of Elanco Animal Health will change in view of the company's plans for further operations in Russia.
Manufacturers of veterinary drugs from Egypt are exploring opportunities to export their products to Russia and the common market of the Eurasian Economic Union
Members of AVPHARM are to continue supplying veterinary medicinal products as long as the national legislation allows.
It is now possible to learn why commonly used VMPs disappeared and report their shortage.
A section with open data for industry participants was published on the AVPHARM website. The first data set summarizes information about positive conclusions issued based on the results of inspections of domestic and foreign production sites for compliance with the EAEU GMP.
Heads of inspection bodies of the Russian Federation and the Republic of Belarus, representatives of the Eurasian Economic Commission and business, as well as Russian and international experts in the field of Good Manufacturing Practice gathered at a round table organized by AVPHARM at the site of the 7th All-Russian GMP Conference on September, 7.
Industry unions have strongly opposed the idea of the Ministry of Agriculture of Russia to allocate preferential loans for the purchase of veterinary medicinal products only if at least 50% of Russian-made VMPs are purchased. Associations of poultry farmers, and meat and milk producers saw the risks of reducing the efficiency and considered it expedient not to limit the availability of drugs of foreign production.
The Association spoke on the topic “Foreign veterinary drugs for non-productive animals: prospects and risks for the Russian market” at the event in the Chamber of Commerce and Industry of the Russian Federation on July 13. The market of the veterinary medicines for pets is an extensive, constantly developing area of veterinary pharmaceuticals.
The roundtable discussion on the Rules on regulation of veterinary medicinal product circulation in the customs territory of the Eurasian Economic Union was held at the site of “Delovaya Rossiya” organization (All-Russia Public Organization “Business Russia”) on May 27. Although the new rules will be introduced in 2024, the participants of the veterinary market have accumulated a significant number of questions and comments to the document.
The Council of the Eurasian Economic Commission approved the Rules on regulation of veterinary medicinal product circulation in the customs territory of the Eurasian Economic Union.
